Normal view MARC view ISBD view

Conventional Radioiodine Therapy for Differentiated Thyroid Cancer. [Review] - 2019

Available online from MWHC library: 1996 - present

Copyright (c) 2018 Elsevier Inc. All rights reserved. This article presents an overview of the use of radioactive iodine (131-I) in the treatment of patients with differentiated thyroid cancer. Topics reviewed include definitions; staging; the 2 principal methods for selection of 131-I dosage; the indications for ablation, adjuvant treatment, and treatment; the recommendations for the use of 131-I contained in the guidelines of the American Thyroid Association and the Society of Nuclear Medicine and Molecular Imaging; the dosage recommendations and selection of dosage approach for 131-I by these organizations; the use of recombinant human thyrotropin for radioiodine ablation, adjuvant therapy, or treatment; and the MedStar Washington Hospital Center approach.


English

ISSN: 0889-8529

Standard No.: 10.1016/j.ecl.2018.11.005 [doi] S0889-8529(18)30592-9 [pii]

Subjects--Topical Terms:
*Iodine Radioisotopes/tu [Therapeutic Use]
*Thyroid Neoplasms/rt [Radiotherapy]
Humans
Iodine Radioisotopes/ad [Administration & Dosage]

Subjects--Geographic Terms:
MedStar Health Research Institute
MedStar Washington Hospital Center

Index Terms--Occupation:
Medicine/Endocrinology
Medicine/Nuclear Medicine

Index Terms--Function:
Journal Article
Review